About: Olivier Bernard

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Olivier Bernard Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

biomedical researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) 研究者 (ja) изилдөөчү (ky) 研究者 (zh) onderzoeker (nl) biomedical researcher (en)
rdfs:label	Olivier Bernard (en) Olivier Bernard (fr) Bernard O (nl)
skos:prefLabel	Olivier Bernard (en) Olivier Bernard (fr) Bernard O (nl)
name	Olivier Bernard (en) Olivier Bernard (fr) Bernard O (nl)
given name	wds:Q70510883-2fc444ea-4726-7489-7f1d-b237b4a99d22
given name	Olivier
instance of	wds:Q70510883-4C2EEC70-A43B-4FFD-A9FC-2A99491D05D7
instance of	Homo sapiens
skos:altLabel	O Bernard (en)
occupation	wds:Q70510883-884B51E9-534B-469A-BE08-C6B2B26F1475
sex or gender	wds:Q70510883-ecd48a7e-1d52-46dd-94fe-f953917c99d7
VIAF ID	wds:Q70510883-6FFD3DA7-874F-4C5F-97F9-CCDC2992BD0B
IdRef ID	wds:Q70510883-aa264183-3e3d-4058-beac-989441a9ab03
date of death	wds:Q70510883-859CC3CE-9F64-441C-84CC-F7EBA6542389
family name	wds:Q70510883-1C775B63-8005-4414-92BB-444542D58DC4
VIAF ID	http://viaf.org/viaf/197832898
IdRef ID	http://www.idref.fr/074207059/id
occupation	researcher
sex or gender	male
VIAF ID	197832898
IdRef ID	074207059
date of death	2014-01-01 00:00:00Z (xsd:dateTime)
family name	Bernard
ORCID iD	wds:Q70510883-F15F60F8-5F3F-4A3E-8130-9C6652C8C3E4
ORCID iD	https://orcid.org/0000-0002-0463-9747
ORCID iD	0000-0002-0463-9747
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70510883
is author of	TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. TET2 and DNMT3A mutations in human T-cell lymphoma The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia TEL-JAK2 transgenic mice develop T-cell leukemia. New mutations and pathogenesis of myeloproliferative neoplasms. Activating mutations in human acute megakaryoblastic leukemia. Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. CALM-AF10 fusion gene in leukemias: simple and inversion-associated translocation (10;11). Mutations of ASXL1 gene in myeloproliferative neoplasms. Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. The TEL gene products: nuclear phosphoproteins with DNA binding properties The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications Expression of tal-1 and GATA-binding proteins during human hematopoiesis Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). TET proteins and the control of cytosine demethylation in cancer Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Acquired initiating mutations in early hematopoietic cells of CLL patients NUP98-MLL fusion in human acute myeloblastic leukemia. NUP98–HMGB3: a novel oncogenic fusion TEL is a sequence-specific transcriptional repressor In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells Prognostic score including gene mutations in chronic myelomonocytic leukemia. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Molecular Cytogenetics of t(12;21)(p13;q22) Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia The transcription factor Srf regulates hematopoietic stem cell adhesion Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia. A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. MLL-AF1q fusion resulting from t(1;11) in acute leukemia t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2 HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32) A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software